Seidman, Stuart N. MD*†; Orr, Guy MD‡; Raviv, Gil MD§∥; Levi, Rachel BA‡; Roose, Steven P. MD*†; Kravitz, Efrat BSc‡∥; Amiaz, Revital MD‡∥; Weiser, Mark MD‡∥
From the *Department of Psychiatry, College of Physicians and Surgeons of Columbia University; †New York State Psychiatric Institute, New York, NY; Departments of ‡Psychiatry and §Urology, Chaim Sheba Medical Center, Tel Hashomer; and ∥Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Received November 24, 2008; accepted after revision March 2, 2009.
Reprints: Stuart N. Seidman, MD, Department of Psychiatry, College of Physicians and Surgeons of Columbia University, 1051 Riverside Dr Unit 98, New York, NY 10032 (e-mail: [email protected]).
This research was funded by grants to S.N.S. from the National Institute of Mental Health (MH01740) and from the National Alliance for Research on Schizophrenia and Depression (Young Investigator Award).
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML andPDF versions of this article on the Journal's Website (www.psychopharmacology.com).
doi: 10.1097/JCP.0b013e3181a39137
